STOCK TITAN

Edgewell Personal Care grants Dunham 2,750 stock awards

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Edgewell Personal Care reported a grant of 2,750 restricted stock equivalents to Chief Accounting Officer John M. Dunham on November 13, 2026. On November 16, 2026, 1,196 restricted stock equivalents vested and converted into 1,196 common shares, and 321 shares were withheld to pay tax liability. The reported position after the conversion was 2,390 restricted stock equivalents.

Insider DUNHAM JOHN M
Role Chief Accounting Officer
Type Security Shares Price Value
Exercise Restricted Stock Equivalent 11-14-2025 F3 1,196 $0.00 $0.00
Exercise Common Stock 1,196 $0.00 $0.00
Tax Withholding Common Stock F1 321 $28.38 $9K
Grant/Award Restricted Stock Equivalent 11-13-2026 F2 2,750 $0.00 $0.00
Holdings After Transaction: Restricted Stock Equivalent 11-13-2026 — 2,750 shares (Direct); Restricted Stock Equivalent 11-14-2025 — 2,390 shares (Direct); Common Stock — 1,208 shares (Direct)
Footnotes (3)
  1. F1. Shares withheld as payment of a tax liability on vesting of performance stock equivalents.
  2. F2. One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/13/2027, 11/13/2028 and 11/13/2029 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.
  3. F3. Restricted Stock Equivalents vested & converted into shares of EPC common stock.
Restricted stock equivalents granted 2,750 equivalents Grant to John M. Dunham on November 13, 2026
Restricted stock equivalents converted 1,196 equivalents Vested and converted on November 16, 2026
Common shares acquired 1,196 shares Received upon conversion on November 16, 2026
Shares withheld for tax liability 321 shares On November 16, 2026
Restricted stock equivalents following conversion 2,390 equivalents Reported position after the November 16, 2026 conversion
Price per share for tax withholding $28.38 per share Reported for the 321 shares withheld on November 16, 2026
Restricted Stock Equivalents financial
"Restricted Stock Equivalents vested & converted into shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Edgewell shares did John M. Dunham receive on November 16, 2026?

He received 1,196 common shares when 1,196 restricted stock equivalents vested and converted on November 16, 2026. Another 321 shares were withheld as payment of tax liability.

When do John M. Dunham's new Edgewell restricted stock equivalents vest?

One-third are scheduled to vest and convert into Edgewell common stock on November 13, 2027, November 13, 2028 and November 13, 2029, if he is employed on those dates. All or a portion may also vest upon death, disability, a change in control or certain termination events.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DUNHAM JOHN M

(Last)(First)(Middle)
C/O EDGEWELL PERSONAL CARE COMPANY
6 RESEARCH DRIVE

(Street)
SHELTON CONNECTICUT 06484

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/16/2026M1,196A$01,529D
Common Stock11/16/2026F321(1)D$28.381,208D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Equivalent 11-13-2026$011/13/2026A2,75011/15/2027 (2)Common Stock2,750$02,750D
Restricted Stock Equivalent 11-14-2025$011/16/2026M1,19611/16/2026 (3)Common Stock1,196$02,390D
Explanation of Responses:
1. Shares withheld as payment of a tax liability on vesting of performance stock equivalents.
2. One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/13/2027, 11/13/2028 and 11/13/2029 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.
3. Restricted Stock Equivalents vested & converted into shares of EPC common stock.
/s/ John M. Dunham11/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading